L. Mangel

440 total citations
18 papers, 342 citations indexed

About

L. Mangel is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiation. According to data from OpenAlex, L. Mangel has authored 18 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 5 papers in Radiation. Recurrent topics in L. Mangel's work include Advanced Radiotherapy Techniques (5 papers), Breast Cancer Treatment Studies (4 papers) and Radiation Therapy and Dosimetry (3 papers). L. Mangel is often cited by papers focused on Advanced Radiotherapy Techniques (5 papers), Breast Cancer Treatment Studies (4 papers) and Radiation Therapy and Dosimetry (3 papers). L. Mangel collaborates with scholars based in Hungary, France and Poland. L. Mangel's co-authors include Tibor Major, György Németh, A. Somogyi, János Fodor, Csaba Polgár, Zoltán Takácsi‐Nagy, Zoltán Sulyok, Miklós Kásler, Zsolt Orosz and Róbert Farkas and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

L. Mangel

17 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Mangel Hungary 10 201 135 95 93 77 18 342
Sara Lucidi Italy 7 215 1.1× 97 0.7× 78 0.8× 49 0.5× 72 0.9× 15 352
Anke Keller Germany 12 325 1.6× 239 1.8× 144 1.5× 85 0.9× 129 1.7× 19 499
Francisca Ong Netherlands 10 173 0.9× 60 0.4× 123 1.3× 165 1.8× 46 0.6× 15 372
Heike Scheithauer Germany 13 130 0.6× 107 0.8× 34 0.4× 69 0.7× 101 1.3× 15 377
Hyun Soo Shin South Korea 13 189 0.9× 66 0.5× 142 1.5× 217 2.3× 47 0.6× 36 436
Tingyong Fan China 11 65 0.3× 91 0.7× 61 0.6× 158 1.7× 132 1.7× 34 365
Helen Mayles United Kingdom 13 308 1.5× 351 2.6× 157 1.7× 170 1.8× 195 2.5× 33 750
Samuel Leung France 7 93 0.5× 48 0.4× 60 0.6× 142 1.5× 68 0.9× 7 377
Allen G. Meek United States 6 78 0.4× 62 0.5× 40 0.4× 66 0.7× 52 0.7× 8 323
Michael Yassa Canada 9 101 0.5× 90 0.7× 54 0.6× 38 0.4× 54 0.7× 28 241

Countries citing papers authored by L. Mangel

Since Specialization
Citations

This map shows the geographic impact of L. Mangel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Mangel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Mangel more than expected).

Fields of papers citing papers by L. Mangel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Mangel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Mangel. The network helps show where L. Mangel may publish in the future.

Co-authorship network of co-authors of L. Mangel

This figure shows the co-authorship network connecting the top 25 collaborators of L. Mangel. A scholar is included among the top collaborators of L. Mangel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Mangel. L. Mangel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Choueiri, Toni K., Judit Kocsis, Russell K. Pachynski, et al.. (2019). Results of the phase II TRAXAR study: A randomized phase II trial of axitinib and TRC105 (TRAX) versus axitinib (AX) alone in patients with advanced or metastatic renal cell carcinoma (mRCC). Annals of Oncology. 30. v362–v363. 4 indexed citations
3.
Bonvalot, S., Piotr Rutkowski, Juliette Thariat, et al.. (2018). A phase II/III trial of hafnium oxide nanoparticles activated by radiotherapy in the treatment of locally advance soft tissue sarcoma of the extremity and trunk wall. Annals of Oncology. 29. viii753–viii753. 9 indexed citations
4.
Bonvalot, Sylvie, Piotr Rutkowski, Juliette Thariat, et al.. (2018). Act.in.Sarc: An International Randomized Phase III Trial Evaluating Efficacy and Safety of First-in-Class NBTXR3 Hafnium Oxide Nanoparticles Activated By Preoperative Radiotherapy in Locally Advanced Soft Tissue Sarcoma. International Journal of Radiation Oncology*Biology*Physics. 102(5). 1606–1606. 1 indexed citations
5.
Laé, Marick, Juliette Thariat, Sébastien Carrère, et al.. (2018). Hafnium Oxide Nanoparticle Activated By Radiation Therapy Generates an Anti-Tumor Immune Response. International Journal of Radiation Oncology*Biology*Physics. 102(3). S204–S205. 4 indexed citations
6.
Zemplényi, Antal, Zoltán Kaló, György Kovács, et al.. (2016). Cost-effectiveness analysis of intensity-modulated radiation therapy with normal and hypofractionated schemes for the treatment of localised prostate cancer. European Journal of Cancer Care. 27(1). e12430–e12430. 47 indexed citations
7.
Zemplényi, Antal, Zoltán Kaló, I Boncz, D. Endrei, & L. Mangel. (2015). A Microcosting Study Of Radiation Therapy In Localized Prostate Cancer Patients In A Hungarian Tertiary Oncology Center. Value in Health. 18(7). A354–A354.
9.
Farkas, Róbert, Éva Pozsgai, András Szigeti, et al.. (2011). Correlation between tumor-associated proteins and response to neoadjuvant treatment in patients with advanced squamous-cell esophageal cancer.. PubMed. 31(5). 1769–75. 13 indexed citations
11.
Major, Tibor, et al.. (2004). Brachytherapy of Vestibular Schwannomas: Report of Three Cases. min - Minimally Invasive Neurosurgery. 47(6). 382–385. 2 indexed citations
12.
Polgár, Csaba, Zoltán Sulyok, János Fodor, et al.. (2002). Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: Five‐year results of a phase I–II study and initial findings of a randomized phase III trial. Journal of Surgical Oncology. 80(3). 121–128. 174 indexed citations
13.
Fodor, János, Csaba Polgár, Tibor Major, et al.. (2002). The time-course of metastases from breast cancer after mastectomy and breast-conserving surgery with and without isolated local–regional recurrence. The Breast. 11(1). 53–57. 10 indexed citations
14.
Mangel, L., et al.. (2002). CT densitometry of the brain: a novel method for early detection and assessment of irradiation induced brain edema.. PubMed. 49(4). 237–42. 9 indexed citations
15.
Fodor, János, Tibor Major, L. Mangel, et al.. (2001). [The effect of tumour bed boost on local control after breast conserving surgery. First results of the randomized boost trial of the National Institute of Oncology]. PubMed. 45(5). 385–391. 9 indexed citations
16.
Mangel, L., J. Julow, Tibor Major, et al.. (2000). [CT- and MRI-guided conformal interstitial and external beam radiotherapy of primary brain tumors: prospects in Hungary].. PubMed. 141(31). 1703–9. 2 indexed citations
17.
Julow, J., et al.. (2000). The Application of Image Fusion in Stereotactic Brachytherapy of Brain Tumours. Acta Neurochirurgica. 142(11). 1253–1258. 22 indexed citations
18.
Major, Tibor, L. Mangel, Zoltán Takácsi‐Nagy, et al.. (2000). 48 Sole HDR-brachytherapy after breast conserving surgery: 4 year results of a pilot study and initial findings of a randomized phase III trial. Radiotherapy and Oncology. 55. 31–31. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026